This week, we will discuss the final results of the NEFIGARD trial with the GFR slope data. Is targeted release budesonide aka Nefecon really a way to provide steroid efficacy without steroid side effects?
This week, we tag along with NephMadness. It will be hard to stay impartial while discussing the role of angiogenic and antiangiogenic factors in severe preeclampsia prognosis.
This week, during kidney month and NephMadness season, we will discuss the USRDS report as well as the ISN Global Kidney Health Atlas report from 2024.
This week, we discuss the discovery that peritoneal membrane water transport, and PD outcomes, are influenced by genetic variations in the Aquaporin 1 channel.
When a study is negative the work is not done. Time to separate a negative trial from an underpowered one. Learn how to think about this with Manasi Bapat.
Timothy Yau teaches electrolyte free water. This is a concept that you will need to understand to get through next week's NephJC on sodium, water and the mission to Mars.